Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Insight Agents has reported the European launch of two new generic contrast media solutions for injection. Magnegita 500 micromol/ml is about to be introduced in 22 European countries and Iopamigita 300mg Iod/ml will be available for X-ray/CT in Germany.
Subscribe to our email newsletter
At the same time, Insight Agents has presented a business model, which includes a range of services to radiologists. These include top purchase conditions from one of Europe’s largest group purchasing organizations in radiology. Instead of an expensive sales force, Insight Agents said that it provides value-added consulting services for hospital and private radiologists.
Johannes Schmidt-Tophoff, CEO of Insight Agents, said: “Our one-stop product range with surprisingly wide indication lists has a significant substitution potential in MRI and CT. As of today, our pro-active ingredients contribute to considerable cost savings in the health care sector. In addition, Insight Agents offers shares to radiologists and is committed to working hard for a potential benefit to radiology budgets and lobbying.”